Your next question comes from the line of Ken Goldman with JPMorgan.
I guess my question is on DSD. You talked about your desire to stick with it, but I guess I would ask why, just given few things right. We have the malware incident I guess exposing some of the unexpected vulnerabilities of the system. I mean your biggest competitor in U.S. biscuits is probably doing better than some feared I mean it’s hard to tell exactly how much of that is unique, because of your challenges right. We have the higher cost of transportation and some of your bigger customers are demanding much better fill rates, they’re trying to get trucks out of their parking lot. So I guess I'm curious where is the evidence that we can see on the outside anyway that DSD is really worth the what I guess would be hundreds of basis points to that segment’s operating income?
Dirk Van de Put
Well, first of all, I'm just arriving, and to make decision on these it's a pretty important decision. And on topics difficult to read what exactly is going on, we’re seeing the issues that we've been having. Overall, I think it's a powerful asset for our U.S. biscuit business. And so I do want to take some time to go through this and study and see what the cost benefit equitation is for or keeping it or getting out of it. So it's part of our strategic review. We hope to have clarity near the middle of the year. But from my perspective, it’s a bit early to make a decision on that.
Sounds like a decision will be made soon according to this q&a with the shareholders